PharVision Advisers’s Grifois GRFS Stock Holding History

PharVision Advisers’s Portfolio GRFS Stock Details GRFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-34,831	Closed	-$347K	–	813
2025 Q3	$347K	Buy	+34,831	New	+$348K	0.2%	143

Other funds holding GRFS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PharVision Advisers's GRFS Position: Q4 2025 in Review

PharVision Advisers sold out of Grifois (GRFS) in Q4 2025, closing a stake of 34,831 shares — an estimated $347K sold.

PharVision Advisers first reported a position in GRFS in Q3 2025 and held it in 1 quarter. The position peaked at $347K in Q3 2025. 182 funds tracked by Wall St. Rank hold GRFS as of Q4 2025.

PharVision Advisers reported no remaining Grifois position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 34,831 Grifois shares in Q4 2025, an estimated $347K.
PharVision Advisers first reported a position in Grifois in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Grifois position peaked at $347K in Q3 2025.
182 funds tracked by Wall St. Rank held Grifois as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.